These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26377185)

  • 1. Dopamine agonist inhibits vascular endothelial growth factor protein production and secretion in granulosa cells.
    Ferrero H; García-Pascual CM; Pellicer N; Simón C; Pellicer A; Gómez R
    Reprod Biol Endocrinol; 2015 Sep; 13():104. PubMed ID: 26377185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in vitro: implications for treatment of ovarian hyperstimulation syndrome with dopamine receptor 2 agonists.
    Ferrero H; García-Pascual CM; Gómez R; Delgado-Rosas F; Cauli O; Simón C; Gaytán F; Pellicer A
    Fertil Steril; 2014 May; 101(5):1411-8. PubMed ID: 24581579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidences for the existence of a low dopaminergic tone in polycystic ovarian syndrome: implications for OHSS development and treatment.
    Gómez R; Ferrero H; Delgado-Rosas F; Gaytan M; Morales C; Zimmermann RC; Simón C; Gaytan F; Pellicer A
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2484-92. PubMed ID: 21646367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in an ovarian hyperstimulation syndrome (OHSS) animal model: implications for treatment of OHSS with dopamine receptor 2 agonists.
    Ferrero H; García-Pascual CM; Gaytán M; Morales C; Simón C; Gaytán F; Pellicer A; Gómez R
    Fertil Steril; 2014 Nov; 102(5):1468-1476.e1. PubMed ID: 25217874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model.
    Gomez R; Gonzalez-Izquierdo M; Zimmermann RC; Novella-Maestre E; Alonso-Muriel I; Sanchez-Criado J; Remohi J; Simon C; Pellicer A
    Endocrinology; 2006 Nov; 147(11):5400-11. PubMed ID: 16901966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated genes and their functional pathways in luteinized granulosa cells from PCOS patients after cabergoline treatment.
    Ferrero H; Díaz-Gimeno P; Sebastián-León P; Faus A; Gómez R; Pellicer A
    Reproduction; 2018 Apr; 155(4):373-381. PubMed ID: 29439093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GnRH Agonist Triggering Modulates PEDF to VEGF Ratio Inversely to hCG in Granulosa Cells.
    Miller I; Chuderland D; Ron-El R; Shalgi R; Ben-Ami I
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1428-36. PubMed ID: 26308290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction.
    Alvarez C; Martí-Bonmatí L; Novella-Maestre E; Sanz R; Gómez R; Fernández-Sánchez M; Simón C; Pellicer A
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2931-7. PubMed ID: 17456571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome.
    Soares SR; Gómez R; Simón C; García-Velasco JA; Pellicer A
    Hum Reprod Update; 2008; 14(4):321-33. PubMed ID: 18385260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor.
    Wang TH; Horng SG; Chang CL; Wu HM; Tsai YJ; Wang HS; Soong YK
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3300-8. PubMed ID: 12107240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and insulin-like growth factor stimulation of vascular endothelial growth factor production by luteinized granulosa cells: comparison between polycystic ovarian syndrome (PCOS) and non-PCOS women.
    Stanek MB; Borman SM; Molskness TA; Larson JM; Stouffer RL; Patton PE
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2726-33. PubMed ID: 17488794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiology and pathology of ovarian hyperstimulation syndrome.
    Gómez R; Soares SR; Busso C; Garcia-Velasco JA; Simón C; Pellicer A
    Semin Reprod Med; 2010 Nov; 28(6):448-57. PubMed ID: 21082502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome.
    Neulen J; Yan Z; Raczek S; Weindel K; Keck C; Weich HA; Marmé D; Breckwoldt M
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1967-71. PubMed ID: 7775647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal mechanisms of vascular endothelial growth factor and interleukin-8 in ovarian hyperstimulation syndrome: dopamine targets their common pathways.
    Chen SU; Chou CH; Lin CW; Lee H; Wu JC; Lu HF; Chen CD; Yang YS
    Hum Reprod; 2010 Mar; 25(3):757-67. PubMed ID: 20008399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulatory and synergistic effects of luteinising hormone and insulin like growth factor 1 on the secretion of vascular endothelial growth factor and progesterone of cultured bovine granulosa cells.
    Schams D; Kosmann M; Berisha B; Amselgruber WM; Miyamoto A
    Exp Clin Endocrinol Diabetes; 2001; 109(3):155-62. PubMed ID: 11409298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of montelukast and cabergoline for prevention of ovarian hyperstimulation syndrome: in an experimental rat model.
    Akman L; Sahin G; Erbas O; Aktug H; Akdogan A; Goker EN; Taskiran D; Tavmergen E
    Gynecol Endocrinol; 2015 May; 31(5):369-73. PubMed ID: 25599748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kisspeptin-10 inhibits OHSS by suppressing VEGF secretion.
    Zhai J; Liu J; Zhao S; Zhao H; Chen ZJ; Du Y; Li W
    Reproduction; 2017 Oct; 154(4):355-362. PubMed ID: 28676533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicle-stimulating hormone and luteinizing hormone/chorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cells from pre- and periovulatory follicles.
    Christenson LK; Stouffer RL
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2135-42. PubMed ID: 9215284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis.
    Delgado-Rosas F; Gómez R; Ferrero H; Gaytan F; Garcia-Velasco J; Simón C; Pellicer A
    Reproduction; 2011 Nov; 142(5):745-55. PubMed ID: 21862695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade.
    Gómez R; Simón C; Remohí J; Pellicer A
    Endocrinology; 2002 Nov; 143(11):4339-48. PubMed ID: 12399430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.